Cochrane · systematic review · CD000060
Combined inhaled anticholinergics and short‐acting beta₂‐agonists for initial treatment of acute asthma in children
Griffiths, B, Ducharme, FM · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
AirwaysAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
1
current version
GRADE rated
1
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Anticholinergic and short‐acting beta2‐agonists versus beta2‐agonists alone (all protocols) for initial treatment of acute asthma in children
Population: children with initial treatment of acute asthma
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Primary outcome: hospital admissions hospital admissions Anticholinergic and short‐acting beta2‐agonists vs beta2‐agonists alone (all protocols) | RR 0.73 [0.63, 0.85] | 19 studies · 2497 participants | High |